#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	11826	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2335	504.7	0	.	n	.	0	C1450T	SNP	1450	1450	C	1778	1778	T	657	T,C	611,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	11826	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2335	504.7	1	SNP	n	C1184T	0	.	.	1184	1184	C	1512	1512	C	699	C	656	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	21522	23S	2890	2890	99.9	23S.l15.c17.ctg.1	3412	627.1	0	.	n	.	0	G1337A	SNP	1337	1337	G	1615	1615	A	707	A,C	660,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	21522	23S	2890	2890	99.9	23S.l15.c17.ctg.1	3412	627.1	0	.	n	.	0	T1971C	SNP	1971	1971	T	2249	2249	C	645	C	602	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	21522	23S	2890	2890	99.9	23S.l15.c17.ctg.1	3412	627.1	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	2875	2875	T	664	T,C	620,2	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	21522	23S	2890	2890	99.9	23S.l15.c17.ctg.1	3412	627.1	1	SNP	n	A2045G	0	.	.	2045	2045	A	2323	2323	A	637	A	607	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	539	37298	blaTEM	861	861	99.88	blaTEM.l6.c17.ctg.1	1477	2509.0	0	.	p	.	0	P12S	NONSYN	34	36	CCC	315	317	TCC	3099;3104;3126	T,A;C,G,T;C,T,A	2908,1;2906,2,1;2918,2,1	.	Betalactam resistance
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1402	folP	852	852	93.78	folP.l15.c4.ctg.1	1485	94.2	0	.	p	.	0	G5V	NONSYN	13	15	GGT	285	287	GTT	92;93;93	G;T;T	85;85;86	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1402	folP	852	852	93.78	folP.l15.c4.ctg.1	1485	94.2	0	.	p	.	0	E12K	NONSYN	34	36	GAA	306	308	AAA	95;95;99	A;A;A	88;88;92	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1402	folP	852	852	93.78	folP.l15.c4.ctg.1	1485	94.2	0	.	p	.	0	F31L	NONSYN	91	93	TTT	363	365	TTG	122;126;127	T;T;G	112;115;114	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1402	folP	852	852	93.78	folP.l15.c4.ctg.1	1485	94.2	0	.	p	.	0	K42Q	NONSYN	124	126	AAA	396	398	CAA	165;164;166	C,A;A;A	157,1;155;158	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1402	folP	852	852	93.78	folP.l15.c4.ctg.1	1485	94.2	0	.	p	.	0	S75P	NONSYN	223	225	TCC	495	497	CCT	171;168;165	C;C;T	158;158;151	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1402	folP	852	852	93.78	folP.l15.c4.ctg.1	1485	94.2	0	.	p	.	0	V87A	NONSYN	259	261	GTA	531	533	GCA	151;151;152	G;C;A	143;145;145	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1402	folP	852	852	93.78	folP.l15.c4.ctg.1	1485	94.2	0	.	p	.	0	V130L	NONSYN	388	390	GTC	660	662	CTC	185;184;185	C;T;C	174;171;174	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1402	folP	852	852	93.78	folP.l15.c4.ctg.1	1485	94.2	0	.	p	.	0	R135C	NONSYN	403	405	CGC	675	677	TGT	195;195;194	T;G;T	177;181;176	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1402	folP	852	852	93.78	folP.l15.c4.ctg.1	1485	94.2	0	.	p	.	0	T137A	NONSYN	409	411	ACG	681	683	GCG	197;198;199	G;C,T;G	183;183,1;183	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1402	folP	852	852	93.78	folP.l15.c4.ctg.1	1485	94.2	0	.	p	.	0	E151K	NONSYN	451	453	GAA	723	725	AAG	196;196;196	A;A;G	180;183;182	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1402	folP	852	852	93.78	folP.l15.c4.ctg.1	1485	94.2	0	.	p	.	0	T152N	NONSYN	454	456	ACC	726	728	AAT	199;198;197	A;A;T	186;184;183	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1402	folP	852	852	93.78	folP.l15.c4.ctg.1	1485	94.2	0	.	p	.	0	F218L	NONSYN	652	654	TTT	924	926	TTG	124;122;123	T;T;G	119;119;120	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1402	folP	852	852	93.78	folP.l15.c4.ctg.1	1485	94.2	1	SNP	p	R228S	1	R228S	NONSYN	682	684	CGT	954	956	AGC	96;96;95	A;G;C	95;95;93	folP.Neisseria_meningitidis_M01_240149_v1_00504:1:1:R228S:folP.228S:Resistance to sulphonamides	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1402	folP	852	852	93.78	folP.l15.c4.ctg.1	1485	94.2	0	.	p	.	0	V251L	NONSYN	751	753	GTG	1023	1025	CTG	75;75;75	C;T;G	70;68;68	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1402	folP	852	852	93.78	folP.l15.c4.ctg.1	1485	94.2	0	.	p	.	0	A253S	NONSYN	757	759	GCT	1029	1031	TCC	68;68;68	T;C;C	68;67;68	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1402	folP	852	852	93.78	folP.l15.c4.ctg.1	1485	94.2	0	.	p	.	0	A258V	NONSYN	772	774	GCG	1044	1046	GTG	83;83;85	G;T;G	79;79;83	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1402	folP	852	852	93.78	folP.l15.c4.ctg.1	1485	94.2	0	.	p	.	0	V275A	NONSYN	823	825	GTG	1095	1097	GCG	108;107;104	G;C;G	106;103;102	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5138	gyrA	2751	2751	100.0	gyrA.l6.c30.ctg.1	3405	150.4	1	SNP	p	S91F	0	.	.	271	273	TCC	596	598	TCC	166;164;169	T;C;C,T	156;152;156,1	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5138	gyrA	2751	2751	100.0	gyrA.l6.c30.ctg.1	3405	150.4	1	SNP	p	D95G	0	.	.	283	285	GAC	608	610	GAC	172;170;168	G;A;C	161;159;158	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5138	gyrA	2751	2751	100.0	gyrA.l6.c30.ctg.1	3405	150.4	1	SNP	p	D95N	0	.	.	283	285	GAC	608	610	GAC	172;170;168	G;A;C	161;159;158	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_M_01390	mtrR.WHO_M_01390	1	1	531	1520	mtrR	633	633	99.68	mtrR.l15.c30.ctg.1	1368	110.7	0	.	p	.	0	Q133trunc	TRUNC	397	397	C	843	843	T	159	T	152	.	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	746	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1072	69.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4448	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3041	145.7	0	.	p	.	0	V384I	NONSYN	1150	1152	GTC	1601	1603	ATC	195;194;193	A;T;C	181;180;177	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4448	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3041	145.7	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1754	1756	GCA	184;184;182	G;C;A	164;167;164	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4448	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3041	145.7	1	SNP	p	D86N	0	.	.	256	258	GAC	707	709	GAC	167;167;170	G;A;C	161;161;166	parC.WHO_G_00206c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4448	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3041	145.7	1	SNP	p	S87R	0	.	.	259	261	AGT	710	712	AGT	174;173;174	A;G;T	170;169;167	parC.WHO_G_00206c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4448	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3041	145.7	1	SNP	p	S87I	0	.	.	259	261	AGT	710	712	AGT	174;173;174	A;G;T	170;169;167	parC.WHO_G_00206c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4448	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3041	145.7	1	SNP	p	S87W	0	.	.	259	261	AGT	710	712	AGT	174;173;174	A;G;T	170;169;167	parC.WHO_G_00206c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4448	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3041	145.7	1	SNP	p	S88P	0	.	.	262	264	TCC	713	715	TCC	174;179;182	T;C;C	168;171;175	parC.WHO_G_00206c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3826	parE	1986	1986	99.95	parE.l15.c30.ctg.1	2817	135.3	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1593	1595	GGC	194;193;194	G;G;C	178;177;175	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.14.001	penA.14.001	1	1	27	3468	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2288	150.4	1	SNP	p	A311V	0	.	.	931	933	GCA	1225	1227	GCA	186;186;187	G;C;A	178;178;179	penA.14.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3468	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2288	150.4	1	SNP	p	I312M	0	.	.	934	936	ATC	1228	1230	ATC	184;184;186	A;T;C	176;177;177	penA.14.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3468	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2288	150.4	1	SNP	p	V316P	0	.	.	946	948	GTG	1240	1242	GTG	193;195;194	G;T;G	184;183;182	penA.14.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3468	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2288	150.4	1	SNP	p	V316T	0	.	.	946	948	GTG	1240	1242	GTG	193;195;194	G;T;G	184;183;182	penA.14.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3468	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2288	150.4	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1744	1746	ACC	200;199;199	A;C;C	181;185;185	penA.14.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3468	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2288	150.4	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1798	1800	GCG	200;199;199	G;C;G	180;156;174	penA.14.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3468	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2288	150.4	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1798	1800	GCG	200;199;199	G;C;G	180;156;174	penA.14.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3468	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2288	150.4	1	SNP	p	G543S	0	.	.	1627	1629	GGT	1921	1923	GGT	161;159;153	G;G;T	154;153;148	penA.14.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3468	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2288	150.4	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1930	1932	GGC	141;141;141	G;G;C	136;136;135	penA.14.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3468	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2288	150.4	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1948	1950	CCG	126;126;123	C,G;C,G;GCCC,GCCCC	98,4;99,1;91,1	penA.14.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	5094	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	2975	170.3	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1530	1532	CTG	205;205;205	C;T,C;G	182;182,1;181	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2040	porA	1146	1146	99.74	porA.l15.c4.ctg.1	1763	114.8	0	.	p	.	0	S22G	NONSYN	64	66	AGC	372	374	GGC	131;129;128	G,A;G;C	120,1;120;120	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2040	porA	1146	1146	99.74	porA.l15.c4.ctg.1	1763	114.8	0	.	p	.	0	M83fs	FSHIFT	247	247	A	554	554	C	170	C	156	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2504	porB1b	1035	1035	98.66	porB1b.l6.c4.ctg.1	1616	154.1	0	.	p	.	0	Y211fs	FSHIFT	631	631	T	969	969	T	186	T	176	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2504	porB1b	1035	1035	98.66	porB1b.l6.c4.ctg.1	1616	154.1	1	SNP	p	G120K	0	.	.	358	360	GGT	696	698	GGT	197;196;197	G;G;T	181;181;176	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2504	porB1b	1035	1035	98.66	porB1b.l6.c4.ctg.1	1616	154.1	1	SNP	p	A121D	0	.	.	361	363	GCC	699	701	GCC	195;195;197	G;C;C,T	178;181;183,1	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2504	porB1b	1035	1035	98.66	porB1b.l6.c4.ctg.1	1616	154.1	1	SNP	p	A121N	0	.	.	361	363	GCC	699	701	GCC	195;195;197	G;C;C,T	178;181;183,1	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9118	rpoB	4179	4179	99.95	rpoB.l15.c4.ctg.1	4939	184.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	962	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	907	105.0	1	SNP	p	V57M	1	.	.	169	171	ATG	464	466	ATG	217;217;216	A;T;G,C	206;203;202,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
